Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01096992
Brief Title: Fludarabine, Bendamustine, and Rituximab (FBR) for Relapsed Chronic Lymphocytic Leukemia (CLL)

First Submitted : March 30, 2010
First Submitted that Met QC Criteria : March 30, 2010
First Posted : March 31, 2010 (Estimate)

Results First Submitted : April 24, 2018
Results First Submitted that Met QC Criteria : September 24, 2019
Results First Posted : September 25, 2019

Last Update Submitted that Met QC Criteria : September 24, 2019
Last Update Posted : September 25, 2019